Federal contract award
W81K0421F0156
SARS-COV-2 CARTRIDGES FOR CEPHEID MACHINES. SOLE SOURCE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M USA HCA |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | W81K0420D0008 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $4.7M |
| Current contract value | $4.7M |
| Potential contract value / ceiling | $4.7M |
| Start date | Apr 22, 2021 |
| Current end date | Apr 21, 2022 |
| Potential end date | Apr 21, 2022 |
| Latest award activity | Sep 18, 2021 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 18, 2021 | P00002 | $3.2M | MODIFICATION TO INCREASE FUNDING AND QUANTITIES OF CEPHEID TEST KITS TO COVER THE DELTA VARIANT. SARS-COV-2/FLU/RSV (10 TETS PER KIT) |
| Apr 23, 2021 | P00001 | $0 | MODIFICATION TO INCLUDE SHIPPING LOCATIONS LEFT OFF DELIVERY ORDER. SAARS-COV-2 CARTRIDGES |
| Apr 22, 2021 | 0 | $1.5M | SARS-COV-2 CARTRIDGES FOR CEPHEID MACHINES. SOLE SOURCE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.